| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2024 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 500 | $43.43 | $21,714.15 | -0.6% | -11.3% | -34.9% | |
| Apr 1, 2024 | NBIX Neurocrine Biosciences Inc | Delaet Ingrid67 | Chief Regulatory Officer | Sell | 272 | $137.30 | $37,345.60 | -3.5% | -0.9% | -24.3% | |
| Apr 1, 2024 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 2,503 | $15.65 | $39,171.95 | -1.5% | +36.8% | +98.3% | |
| Mar 28, 2024 | VRNO Verano Holdings Corp. | Kalesnik Laura Marie | See Remarks | Sell | 1,569 | $6.17 | $9,682.30 | -2.2% | - | - | |
| Mar 28, 2024 | HROW Harrow, Inc. | Opaleye Management Inc.60 | 10% Owner | Buy | 50,000 | $12.82 | $641,000.00 | +1.4% | +61.3% | +98.1% | |
| Mar 28, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 29,125 | $239.05 | $6,962,298.44 | -17.3% | +38.8% | +33.6% | |
| Mar 27, 2024 | CBSTF Cannabist Co Holdings Inc. | Sirolly David | Chief Legal Officer/ GC | Buy | 14,265 | $0.35 | $4,992.75 | +22.1% | - | - | |
| Mar 27, 2024 | UTHR United Therapeutics Corp | Mesa Nilda47 | Director | Sell | 325 | $237.80 | $77,285.00 | -5.7% | +31.1% | +26.6% | |
| Mar 27, 2024 | EOLS Evolus, Inc. | Moatazedi David68 | See Remarks | Sell | 6,236 | $13.86 | $86,430.96 | -0.9% | -25.4% | -12.6% | |
| Mar 27, 2024 | GTBIF Green Thumb Industries Inc. | Kravitz Bret | General Counsel And Secretary | Sell | 18,316 | $14.10 | $258,255.60 | -2.4% | - | - | |
| Mar 26, 2024 | CBSTF Cannabist Co Holdings Inc. | Hill Julie A | - | Buy | 20,426 | $0.34 | $6,944.84 | +11.2% | - | - | |
| Mar 26, 2024 | VRNO Verano Holdings Corp. | Kalesnik Laura Marie | See Remarks | Sell | 3,760 | $5.45 | $20,491.25 | -4.9% | - | - | |
| Mar 26, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 30,000 | $245.84 | $7,375,339.23 | -24.4% | +28.7% | +25.4% | |
| Mar 26, 2024 | VRNO Verano Holdings Corp. | Tarapchak Richard C | Corporate Controller | Sell | 6,424 | $5.45 | $35,009.52 | -12.4% | - | - | |
| Mar 25, 2024 | DERM Journey Medical Corp | Rosenwald Lindsay A Md64 | Director | Buy | 10,000 | $3.04 | $30,400.00 | +7.4% | +68.8% | +121.9% | |
| Mar 25, 2024 | GTBIF Green Thumb Industries Inc. | Georgiadis Anthony | President | Sell | 22,196 | $13.45 | $298,536.20 | -10.8% | - | - | |
| Mar 25, 2024 | GTBIF Green Thumb Industries Inc. | Kovler Benjamin | Chairman &CEO | Sell | 22,196 | $13.40 | $297,426.40 | -14.0% | - | - | |
| Mar 22, 2024 | HROW Harrow, Inc. | Baum Mark L66 | Chief Executive Officer | Buy | 9,000 | $11.59 | $104,310.00 | +0.4% | +73.3% | +147.0% | |
| Mar 22, 2024 | DERM Journey Medical Corp | Maraoui Claude | President &CEO | Buy | 10,000 | $3.48 | $34,790.00 | +0.5% | +65.8% | +73.9% | |
| Mar 22, 2024 | PLNH Planet 13 Holdings Inc. | Wren Chris | VP Of Operations | Sell | 98,606 | $0.52 | $51,176.51 | -24.4% | - | - | |
| Mar 22, 2024 | DERM Journey Medical Corp | Smith Justin Adam | Director | Buy | 30,000 | $3.47 | $104,100.00 | +28.6% | +65.8% | +73.9% | |
| Mar 22, 2024 | DERM Journey Medical Corp | Rosenwald Lindsay A Md64 | Director | Buy | 20,000 | $3.40 | $68,000.00 | +17.5% | +65.8% | +73.9% | |
| Mar 22, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 30,000 | $236.70 | $7,100,981.03 | -31.0% | +29.9% | +31.6% | |
| Mar 21, 2024 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $236.45 | $1,418,726.00 | -3.7% | +30.4% | +32.1% | |
| Mar 21, 2024 | SUPN Supernus Pharmaceuticals, Inc. | Bhatt Padmanabh P.69 | Sr. VP Of Ip, CSO | Sell | 14,491 | $35.31 | $511,677.21 | -62.8% | -23.8% | -8.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.